CBD and Hemp

A growing number of firms are using genetically engineered yeast to biosynthesize cannabinoids by effectively reverse engineering how Cannabis sativa plants make these molecules (picture: Demetrix)

Demetrix begins demo scale production of rare cannabinoid CBG

By Elaine Watson

Demetrix – one of a new wave of biotech firms producing cannabinoids via biosynthesis (rather than extracting them from cannabis plants) – has commenced 15,000-liter demo-scale fermentation production of CBG (cannabigerol), the first rare cannabinoid...

Is FDA open to entertaining an NDI for CBD products?

Is FDA open to entertaining an NDI for CBD products?

By Stephen Daniells

The US Food and Drug Administration may be willing to sit down with a company about a possible NDI submission for full-spectrum hemp extracts, says Steve Mister, president and CEO of the Council for Responsible Nutrition (CRN).

© Getty Images Olivier Le Moal

Uphill battle for CBD companies registering trademarks

By Danielle Masterson


The United States Trademark Trial and Appeal Board (TTAB) recently issued a precedential decision that would control future rulings on whether a company could register a trademark for a dietary supplement or food containing cannabidiol (CBD).

Have you registered yet?

How is COVID-19 impacting the hemp-derived CBD market?

By Elaine Watson

How is COVID-19 impacting the hemp-derived CBD market? Are consumers turning to CBD to address anxiety during these times, or when it comes to functional foods, beverages and supplements, are they more likely to spend money on products they believe have...

Getty Images

Texas proposes rules for consumable hemp products

By Hank Schultz

The state of Texas has proposed rules for consumable hemp products that specify processing, testing, labeling and registration requirements. While the rules are characterized as reasonable and well thought out, they represent another patch in a state-by-state...

SōRSE emulsions are currently in around 30 products, including a new line of beverages from startup Mad Tasty

Formulating with CBD: In conversation with SōRSE Technology

By Elaine Watson

While developing new products during a pandemic presents obvious challenges, food and beverage companies remain bullish about the potential for products featuring hemp-derived CBD, says Seattle-based SōRSE Technology, which supports brands looking to...

Getty Images

Curaleaf buoyed by increase in hemp oil demand during crisis

By Hank Schultz

Consumers seem to be turning to hemp and cannabis products during the current crisis, which has buoyed the near term outlook for Curaleaf, one of the largest companies in the sector, which posted strong revenue growth in its recent annual report.

CBD firm CV Sciences reports 11% rise in sales

CBD firm CV Sciences reports 11% rise in sales

By Danielle Masterson

One of the pioneers of the space topped $53 million in annual revenue, but also recorded a loss as the founders cashed out. The firm also said regulatory uncertainty has increased competition as numerous small brands crowd into the field.

Getty Images

FDA report on CBD seen as ‘disappointing’ recap of status quo

By Hank Schultz, Elaine Watson and Elizabeth Crawford

A report on CBD delivered by FDA Commissioner Dr Stephen Hahn, MD, was seen by food and dietary supplement industry stakeholders as offering little hope of a timely regulatory solution for the ingredient.

Follow us

Products

View more

Webinars